Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

Spexin levels are lower in PCOS patients and linked to metabolic and hormonal issues.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Women with PCOS have higher levels of DHEA, IL-6, and TNF-α.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Men with hair loss have lower SHBG and higher saliva testosterone levels, suggesting increased androgen activity.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Higher BPA levels may be linked to idiopathic hyperandrogenemia in women.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Women with PCOS have lower amylin levels, which are not related to their body weight.

High chromogranin A levels are linked to obesity and inflammation in polycystic ovary syndrome.